Teligent Inc (NASDAQ: TLGT), a specialty generic pharmaceutical firm, revealed Monday that it got the FDA approval for its abbreviated new drug application (ANDA) of Triamcinolone Acetonide Ointment ...

BUENA, N.J., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s ...

Teligent announced that the Food and Drug Administration (FDA) has approved Triamcinolone Acetonide Ointment, 0.1%. Triamcinolone Acetonide Ointment is a topical steroid indicated for the relief of ...

It is the generic version of Delcor Asset Corporation’s Kenalog cream Glenmark Pharmaceuticals, US has been granted final approval by the United States Food & Drug Administration (US FDA) for ...

With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Advisory Alert: It has come to our attention ...

New Delhi, Aug 8: Glenmark Pharmaceuticals has received final nod from the US health regulator for generic Triamcinolone acetonide cream used for reducing itching, redness and swelling on skin.

generic cream Dr. Reddy's Laboratories has announced the launch of Nystatin and Triamcinolone Acetonide Cream, the generic equivalent of Taro Pharmaceutical's Nystatin and Triamcinolone Acetonide ...

Alembic Pharmaceuticals Limited (Alembic) today announced that its joint venture Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its ...

The product is the generic equivalent of nystatin and triamcinolone acetonide cream, USP 1,00,000 units/g-0.1 per cent manufactured by Taro Pharmaceuticals USA Inc, it added. The product is the ...

Share price of Glenmark Pharma gained nearly 2 percent intraday Wednesday on USFDA approval. Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug ...

Alembic Pharmaceuticals (Alembic) today announced that its joint venture Aleor Dermaceuticals (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New ...